Risultati della ricerca - Helmout Modjtahedi

  • Mostra 1 - 8 risultati su 8
Raffina i risultati
  1. 1
    Therapeutic application of monoclonal antibodies in cancer: advances and challenges

    Therapeutic application of monoclonal antibodies in cancer: advances and challenges di Helmout Modjtahedi, S. Ali, Sharadah Essapen

    Pubblicazione 2012
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer

    A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer di Helmout Modjtahedi, Byoung Chul Cho, Martin C. Michel, Flavio Solca

    Pubblicazione 2014
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines

    Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines di Aryan Stanley, G. Hossein Ashrafi, Alan M. Seddon, Helmout Modjtahedi

    Pubblicazione 2017
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

    Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells di Nikolaos Ioannou, Alan M. Seddon, Angus Dalgleish, David Mackintosh, Helmout Modjtahedi

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression andin vitro invasion

    Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression andin vitro invasion di Pornchai O‐charoenrat, Peter Rhŷs‐Evans, Helmout Modjtahedi, William Court, Gary Box, Suzanne A. Eccles

    Pubblicazione 2000
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells

    Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells di Nikolaos Ioannou, Angus Dalgleish, Alan M. Seddon, David Mackintosh, Ulrich Guertler, Flavio Solca, Helmout Modjtahedi

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research

    Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research di Nauf Bou Antoun, Hiba-Tun-Noor A. Mahmood, Anthony J. Walker, Helmout Modjtahedi, Richard Grose, Athina‐Myrto Chioni

    Pubblicazione 2025
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer

    Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer di Helmout Modjtahedi, Tamas Hickish, Margery Nicolson, J. Moore, JM Styles, S. A. Eccles, Elise Jackson, Janine Salter, John Sloane, M. Loreto Spencer, K. Priest, Isabel Smith Zubiaga, Christopher Dean, M. Gore

    Pubblicazione 1996
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: